Surface modification of adenovirus vectors can improve tissue-selective targeting, attenuate immunogenicity, and enable imaging of particle biodistribution, thus significantly improving therapeutic potential. Currently, surface engineering is constrained by a combination of factors, including impact on viral fitness, limited access to functionality, or incomplete control over the site of modification. Here, we report a two-step labeling process involving an initial metabolic placement of a uniquely reactive unnatural amino acid, azidohomoalanine (Aha), followed by highly specific chemical modification. As genetic modification of adenovirus is unnecessary, vector production is exceedingly straightforward. Aha incorporation demonstrated no discernible impact on either virus production or infectivity of the resultant particles. "Click" chemical modification of surface-exposed azides was highly selective, allowing for the attachment of a wide range of functionality. Decoration of human adenovirus type 5 (hAd5) with folate, a known cancer-targeting moiety, provided an ϳ20-fold increase in infection of murine breast cancer cells (4T1) in a folate receptor-dependent manner. This study demonstrates that incorporation of unnatural amino acids can provide a flexible, straightforward route for the selective chemical modification of adenoviral vectors.Adenoviruses (Ad) are widely employed vehicles for gene replacement, cancer gene delivery, and vaccine development. As a result of the broad distribution of the coxsackie-adenovirus receptor (CAR) and significant interactions with alternative receptors, most gene delivery applications benefit from more restrictive vector targeting. As a result, significant effort is being invested in both transductional and transcriptional targeting of these vectors (1, 2, 13). Transductional targeting efforts take advantage of three different methods for capsid remodeling: genetic, noncovalent, and chemical modification. Genetic modification of the coat proteins is the most prevalent method and has been explored at numerous positions on the adenoviral surface; however, due to impact on viral stability and infectivity, most studies focus on the HI loop or C terminus of the fiber protein, the hypervariable region (HVR) within the hexon, and the carboxyl terminus of protein IX (pIX) (4,10,26,35,37). Despite being relatively permissive, genetic alteration of these sites often challenges viral fitness, as evidenced by losses in particle production and infectivity, with such issues determined by the nature and size of modification (12,15,19,22).Noncovalent adenoviral decoration was first demonstrated with chemically modified anti-CAR antibodies. Advantageously, this strategy allows for both detargeting from CARmediated infection and retargeting in a single step (7). Such "molecular bridges" between the vector and the cell-specific receptor consist of two domains; often, the first binds specifically to the primary targeting motif in the knob region, effectively masking it, while the second contains ...